BREAKING: Target Test Prep releases Brand New 2026 On Demand GMAT prep course

Redeem

Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

★★★★★5.0559 reviews
Vote for Target Test Prep, Newsweek Readers’ Choice Awards 2026
NEWSWEEK READERS’ CHOICE 2026

BIG NEWS! Target Test Prep has been nominated, and they’d love your vote!

TTP has worked incredibly hard to build the best test prep experience possible, and winning Newsweek’s 2026 Readers’ Choice Award for Best Test Prep would mean a lot to them. If TTP has helped you, they’d be incredibly grateful for your vote. You can vote once each day through September 9.

Vote for TTP
GMATLiveTeach 7 seats left
Chris Peckover
NEXT LIVE COHORT

Oct 13 to Jan 7, 2027

with Chris Peckover

Schedule
Tue, Thu · 8:00 to 10:00 PM ET
Included
40 live hours + 6 months of GMAT OnDemand
  • Live instruction and real-time questions
  • Class recordings and assigned practice
View class & enroll
Limited cohort · enrollment openTarget Test Prep
EALiveTeach 5 seats left
Logan Thompson
EXECUTIVE ASSESSMENT

Sep 6 to Dec 6, 2026

with Logan Thompson

Schedule
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll
Limited cohort · enrollment openTarget Test Prep
GMATOnDemand Start anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Compare the format, schedule, and included access before enrolling. Prices and seat counts shown reflect the supplied offer details.

A new medication for migraine seems effective

Expert replies
by BTGmoderatorDC » Thu Jan 18, 2018 10:10 pm
A new medication for migraine seems effective, but there is concern that the medication might exacerbate heart disease. If patients with heart disease take the medication under careful medical supervision, however, harmful side effects can definitely be averted. The concern about those side effects is thus unfounded.

The argument depends on which one of the following assumptions?

(A) The new medication actually is effective when taken by patients with heart disease.

(B) No migraine sufferers with heart disease will take the new medication except under careful medical supervision.

(C) Most migraine sufferers who have taken the new medication in trials also had heart disease.

(D) The new medication has various other side effects, but none as serious as that of exacerbating heart disease.

(E) The new medication will displace all migraine medications currently being used.

What is wrong with Option C?

OA B
Join the discussion
Source: — Critical Reasoning |

by elias.latour.apex » Fri Jan 19, 2018 5:37 pm
Another LSAT question -- you seem to love them. Have you ever considered asking GMAT questions in the GMAT forum? Just curious.

What's the conclusion of the argument? It is: The concern about [the medication's] side effects is unfounded.

Why? Because harmful side effects can be averted PROVIDED patients with heart disease take the medication under careful medical supervision.

The assumption is, therefore, that patients with heart disease will take the medication under careful medical supervision. This is answer choice (B).

What's wrong with (C) you ask? Well, it fails the two basic tests for assumption questions:

1) It doesn't answer the question Why?
2) If negated, it doesn't kill the argument.

The concern about [the medication's] side effects is unfounded. Why? Because most migraine sufferers who have taken the new medication in trials also had heart disease.
Does that answer make sense? Does the fact that most migraine sufferers who have taken the medication in trials had heart disease mean necessarily mean that the concern about side effects is unfounded? No, it certainly does not.

What about if it is negated? What if we say: Few migraine sufferers who have taken the new medication in trials also had heart disease. Does that disprove the statement "The concern about [the medication's] side effects is unfounded."? No, it does not.

Accordingly, (C) cannot be the credited response.
Elias Latour
Verbal Specialist @ ApexGMAT
blog.apexgmat.com
+1 (646) 736-7622
Join the discussion